Creative Medical Technology
CELZ
8 hedge funds and large institutions have $71.2K invested in Creative Medical Technology in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
3.46% less ownership
Funds ownership: 5.16% → 1.71% (-3.5%)
20% less funds holding
Funds holding: 10 → 8 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
67% less capital invested
Capital invested by funds: $214K → $71.2K (-$143K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$31.2K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$740 |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$91 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWA
Aaron Wealth Advisors
Chicago,
Illinois
|
-$60.7K |
| 2 |
Two Sigma Advisers
New York
|
-$44.9K |
| 3 |
Two Sigma Investments
New York
|
-$40.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8.23K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$27 |
CELZ Hedge Fund Activity: Q4 2024 in Review
8 of the 7,605 institutional investors tracked by Wall St. Rank reported a position in Creative Medical Technology (CELZ) for Q4 2024, worth a combined $71.2K — down 67% from $214K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CELZ and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $31.2K. The largest seller was Aaron Wealth Advisors, exiting entirely with an estimated $60.7K sold.
- 8 institutional investors held Creative Medical Technology (CELZ) as of Q4 2024, down from 10 in Q3 2024.
- Funds reported $71.2K of Creative Medical Technology stock for Q4 2024, down 67% quarter-over-quarter.
- 1 fund opened new Creative Medical Technology positions in Q4 2024 and 3 closed out, a net change of -2 holders.
- The largest Creative Medical Technology buyer in Q4 2024 was Geode Capital Management, an estimated $31.2K added.
- The largest Creative Medical Technology seller in Q4 2024 was Aaron Wealth Advisors, an estimated $60.7K sold.
Based on aggregated 13F filings for Q4 2024.